ClinicalTrials.govpublic full text
Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN)
morbid obesity, liposomal amphotericin b, ambisome, pharmacokinetics, obesity, bariatric surgery, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 903667
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.